Common Stock, Shares, Outstanding of Trevi Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Trevi Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Trevi Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 128,215,113, a 70% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 128,215,113 +52,760,738 +70% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 121,775,753 +49,183,836 +68% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 99,892,915 +30,932,748 +45% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 93,602,631 +25,318,932 +37% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 75,454,375 +11,599,045 +18% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 72,591,917 +9,493,462 +15% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 68,960,167 +8,894,759 +15% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 68,283,699 +8,340,269 +14% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 63,855,330 +5,532,813 +9.5% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 63,098,455 +23,378,883 +59% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 60,065,408 +29,259,604 +95% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 59,943,430 +31,437,626 +110% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 58,322,517 +39,775,731 +214% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 39,719,572 +18,260,074 +85% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 30,805,804 +10,891,397 +55% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 28,505,804 +9,959,018 +54% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 18,546,786 +225,718 +1.2% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 21,459,498 +3,608,346 +20% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 19,914,407 +2,079,837 +12% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 18,546,786 +712,216 +4% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 18,321,068 +486,498 +2.7% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 17,851,152 +16,582 +0.09% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 17,834,570 +17,395,970 +3966% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 17,834,570 +17,395,970 +3966% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 17,834,570 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 17,834,570 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 438,600 31 Mar 2019 10-Q 14 Jun 2019 2019 Q1
Q4 2018 438,600 31 Dec 2018 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.